en

PRODUCT DETAIL

MabThera 500 mg infúzny koncentrát

Code 46130
MA number EU/1/98/067/002
Product Form: con inf 1x500 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
L01XC02 Rituximab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 02.06.1998
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 18.10.2019
eu-flag.png sk-flag.png